ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
EXPRS2.ST Stock Price Chart
Explore ExpreS2ion Biotech Holding AB (publ) interactive price chart. Choose custom timeframes to analyze EXPRS2.ST price movements and trends.
EXPRS2.ST Company Profile
Discover essential business fundamentals and corporate details for ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Jul 2016
Employees
20.00
Website
https://www.expres2ionbio.comCEO
Bent U. Frandsen MSc
Description
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.
EXPRS2.ST Financial Timeline
Browse a chronological timeline of ExpreS2ion Biotech Holding AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 May 2025
EPS came in at -kr 5.14 , while revenue for the quarter reached kr 1.33M .
Earnings released on 6 Feb 2025
EPS came in at -kr 7.03 , while revenue for the quarter reached kr 599.00K .
Earnings released on 14 Nov 2024
EPS came in at -kr 2.82 , while revenue for the quarter reached kr 459.00K .
Stock split effective on 30 Oct 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Aug 2024
EPS came in at kr 0.69 , while revenue for the quarter reached kr 1.03M .
Earnings released on 16 May 2024
EPS came in at -kr 10.00 , while revenue for the quarter reached kr 923.00K .
Earnings released on 8 Feb 2024
EPS came in at -kr 13.86 , while revenue for the quarter reached kr 1.11M .
Earnings released on 16 Nov 2023
EPS came in at -kr 17.60 , while revenue for the quarter reached kr 1.45M .
Earnings released on 17 Aug 2023
EPS came in at -kr 25.34 , while revenue for the quarter reached kr 1.92M .
Earnings released on 16 May 2023
EPS came in at -kr 27.98 , while revenue for the quarter reached kr 2.57M .
Stock split effective on 24 Mar 2023
Shares were split 43 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Feb 2023
EPS came in at -kr 48.01 , while revenue for the quarter reached kr 972.00K .
Earnings released on 17 Nov 2022
EPS came in at -kr 30.50 , while revenue for the quarter reached kr 833.00K .
Earnings released on 18 Aug 2022
EPS came in at -kr 27.90 , while revenue for the quarter reached kr 1.25M .
Earnings released on 31 May 2022
EPS came in at -kr 15.65 , while revenue for the quarter reached kr 2.03M .
Stock split effective on 12 Apr 2022
Shares were split 41 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Feb 2022
EPS came in at -kr 16.20 , while revenue for the quarter reached kr 3.40M .
Earnings released on 15 Nov 2021
EPS came in at -kr 11.90 , while revenue for the quarter reached kr 2.55M .
Earnings released on 17 Sept 2021
EPS came in at -kr 11.90 , while revenue for the quarter reached kr 4.58M .
Earnings released on 28 Jul 2021
EPS came in at -kr 14.09 , while revenue for the quarter reached kr 1.70M .
Earnings released on 25 Feb 2021
EPS came in at -kr 42.63 , while revenue for the quarter reached -kr 4.73M .
Earnings released on 19 Nov 2020
EPS came in at -kr 9.51 , while revenue for the quarter reached kr 4.02M , missing expectations by -49.80%.
Earnings released on 30 Sept 2020
EPS came in at -kr 10.57 , while revenue for the quarter reached kr 3.14M .
Stock split effective on 30 Sept 2020
Shares were split 27 : 25 , changing the number of shares outstanding and the price per share accordingly.
EXPRS2.ST Stock Performance
Access detailed EXPRS2.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.